CGEM

Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum

09/12 07:00 am

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

08/07 07:00 am

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

04/16 07:00 am

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

02/27 08:00 am

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

11/14 11:01 am

Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market

09/25 08:04 am

Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024

09/14 04:15 am

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib

06/01 07:00 am

Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit

05/24 08:00 am

Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024

05/23 05:04 pm

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

05/15 04:05 pm

Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer

04/29 07:00 am

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

04/24 02:29 pm

Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

04/24 10:09 am

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

04/17 01:36 pm

United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday

04/17 10:55 am

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

04/16 02:17 pm

Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity

04/16 01:32 pm

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

04/16 10:15 am

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

03/14 07:00 am

Ocuphire (OCUP) to Report Q4 Earnings: What's in the Cards?

03/04 09:18 am

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

03/01 08:00 am

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

02/27 12:51 pm

Avalo (AVTX) to Report Q4 Earnings: What's in the Cards?

02/26 12:28 pm

Sarepta (SRPT) to Report Q4 Earnings: Will It Beat Estimates?

02/21 12:24 pm

Perrigo (PRGO) to Report Q4 Earnings: What's in the Cards?

02/20 02:32 pm

Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates?

02/19 12:01 pm

Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

01/30 08:52 am

Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

12/18 05:53 pm

Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-617, a Novel Fusion Protein Uniquely Harnessing Both IL-2 and IL-12 Cytokines

12/14 05:30 pm

Cullinan Oncology to Present Data Demonstrating Progress Across Its Broad Immunotherapy-Pipeline at SITC 2023

11/03 12:01 pm

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023

10/06 11:00 am

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results

08/10 07:00 am

Analyst Ratings for Cullinan Oncology

08/09 02:00 pm

Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

08/09 07:00 am

Cullinan Oncology to Participate in Upcoming Investor Conferences

07/31 08:00 am

Analyst Ratings for Cullinan Oncology

07/07 08:04 am

Analyst Expectations for Cullinan Oncology's Future

06/15 04:01 pm

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023

06/15 11:01 am

Expert Ratings for Cullinan Oncology

06/15 08:01 am

Why Shares of Cullinan Oncology Jumped This Week

06/09 04:07 pm

4 Analysts Have This to Say About Cullinan Oncology

05/26 09:02 am

Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023

05/25 05:00 pm

Cullinan Oncology to Present First Clinical Data Evaluating Novel Anti-MICA/B Antibody, CLN-619, in Patients with Advanced Solid Tumors at ASCO 2023

04/26 10:08 am

Cullinan: Trading Way Below Cash

04/05 01:28 am

What 4 Analyst Ratings Have To Say About Cullinan Oncology

03/27 12:00 pm

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines

03/27 07:00 am

Cullinan Oncology to Present New Preclinical Data for CLN-619 and CLN-617 at the 2023 American Association for Cancer Research Annual Meeting

03/14 04:35 pm

Celularity (CELU) to Report Q4 Earnings: What's in the Cards?

03/06 11:54 am

Cullinan Oncology to Participate in Cowen’s 43rd Annual Health Care Conference

02/27 09:00 am